Stuart Gordon, MD
Gastroenterology · Lebanon, NHNPI 1992711469
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 90.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $21,505 and has fallen 98.4% since, to $350 in 2025. Among gastroenterology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $1172.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$38K
- Ipsen Biopharmaceuticals, Inc$3K
- Vascular Technology, Inc.$350
- Lumendi LLC$236
- Fujifilm Healthcare Americas Corporation$147
Across 15 payments — averaging $3399.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Erbe Elektromedizin GmbH$41K
- US Endoscopy$10K
What the payments were for
- Consulting fees$23,22555%
- Speaking & faculty fees$16,17038%
- Travel & lodging$2,3246%
- Food & beverage$4941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 31 | $38,160 |
| Ipsen Biopharmaceuticals, Inc | 1 | $3,320 |
| Vascular Technology, Inc. | 1 | $350 |
| Lumendi LLC | 2 | $236 |
| Fujifilm Healthcare Americas Corporation | 1 | $147 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL HEMOSTASIS$8,009
- GENERAL - THERAPIES$7,855
- EXALT Model D$4,172
- GENERAL VASCULAR ACCESS$425
- DiLumen$214
- ESD - Core Endoscopy$147
How this compares
$42,213 in reported general payments places this provider in the 90th percentile of 91 gastroenterology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 28 | $57,565 |
| Omeprazole | 127 | $2,467 |
| Esomeprazole Magnesium | 18 | $1,600 |
| Pantoprazole Sodium | 69 | $860 |
| Oxycodone Hcl | 55 | $809 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $189 |
| Prednisone | 14 | $117 |
| Ciprofloxacin Hcl | 21 | $59 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Lebanon
- Lee KaplanLebanon$1.2M
- Corey SiegelLebanon$602K
- Brian LacyLebanon$177K
- Shelby SullivanLebanon$137K
- Michael WinterLebanon$58K
- Timothy GardnerLebanon$17K
- Liam ZakkoLebanon$5K
- Michael CurleyLebanon$4K
- Nicholas HannonLebanon$3K
- Leon McLeanDerry$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.